END STAGE RENAL DISEASE (ESRD)
Clinical trials for END STAGE RENAL DISEASE (ESRD) explained in plain language.
Never miss a new study
Get alerted when new END STAGE RENAL DISEASE (ESRD) trials appear
Sign up with your email to follow new studies for END STAGE RENAL DISEASE (ESRD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can stem cells save dialysis Patients' lifelines?
Disease control OngoingThis early-phase study tests whether a patient's own fat-derived stem cells, applied during surgery, can prevent dialysis fistulas from failing. About 74 adults with end-stage kidney disease who need a new fistula will take part. The goal is to see if the stem cells help keep the…
Matched conditions: END STAGE RENAL DISEASE (ESRD)
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 17, 2026 05:44 UTC
-
Could testosterone boost kidney transplant success?
Disease control OngoingThis study looks at whether giving testosterone to men with low testosterone and end-stage kidney disease before a kidney transplant can help them recover better and more safely. About 50 men will receive testosterone therapy for at least 3 months before their transplant, and the…
Matched conditions: END STAGE RENAL DISEASE (ESRD)
Phase: PHASE1, PHASE2 • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
New dialysis fluid aims to boost nutrition in kidney patients
Disease control ENROLLING_BY_INVITATIONThis study tests whether a dialysis solution containing amino acids can improve the nutritional health of adults with end-stage kidney disease who are already on peritoneal dialysis. Fifty participants will replace one daily dialysis bag with the amino acid solution for six month…
Matched conditions: END STAGE RENAL DISEASE (ESRD)
Phase: PHASE4 • Sponsor: Shanghai 10th People's Hospital • Aim: Disease control
Last updated May 04, 2026 16:21 UTC
-
Dialysis patients get a workout boost: study tests exercise during treatment
Symptom relief OngoingThis study looks at whether adding a structured exercise program during dialysis sessions can help people with end-stage kidney disease improve their muscle strength, walking ability, and overall quality of life. About 60 patients will either receive dialysis alone or dialysis pl…
Matched conditions: END STAGE RENAL DISEASE (ESRD)
Phase: NA • Sponsor: The First People's Hospital of Yunnan • Aim: Symptom relief
Last updated May 15, 2026 11:54 UTC
-
Which numbing drug works best for kidney Patients' surgery?
Symptom relief OngoingThis study tests two local anesthetics, ropivacaine and lidocaine, in 40 adults with end-stage kidney disease who need surgery to create a vein access for dialysis. Neither patients nor surgeons know which drug is used. The goal is to see which provides better pain control during…
Matched conditions: END STAGE RENAL DISEASE (ESRD)
Phase: PHASE4 • Sponsor: The First People's Hospital of Lianyungang • Aim: Symptom relief
Last updated May 15, 2026 11:54 UTC
-
New study aims to break down barriers to kidney transplants
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at whether making changes at the health system level can help more people with end-stage kidney disease start the process of getting a kidney transplant. Researchers will work with five large transplant centers and about 800 dialysis centers to see if these chang…
Matched conditions: END STAGE RENAL DISEASE (ESRD)
Phase: NA • Sponsor: Indiana University • Aim: Knowledge-focused
Last updated May 07, 2026 18:40 UTC
-
Kidney health may change how drug works in body
Knowledge-focused OngoingThis study looks at how the drug LY3537031 moves through the body in people with different levels of kidney function. About 32 adults—some with kidney problems and some healthy—will receive a single dose. The goal is to learn how the kidneys affect drug levels and safety, not to …
Matched conditions: END STAGE RENAL DISEASE (ESRD)
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated Apr 24, 2026 16:20 UTC